Humanigen announced phase III study of Coronavirus treatment planned
On Mar. 20, 2020, Humanigen announced that the company was seeking to conduct a Phase III, randomized, controlled,…
Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
3M outlined actions to support healthcare effort to combat COVID-19
On Mar. 20, 2020, 3M announced it had doubled its global output of N95 respirators to an annual…
PRA Health Sciences launches COVID-19 monitoring program
On Mar. 20, 2020, PRA Health Sciences announced the commercial availability of the COVID-19 Monitoring Program, a mobile…
FDA granted Bellerophon emergency expanded access for INOpulse for treatment of COVID-19 virus
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
Chembio Diagnostics received $4 million purchase order from Bio-Manguinhos for production of DPP COVID-19 IgM/IgG system in Brazil
On Mar. 20, 2020, Chembio Diagnostics announced receipt of a $4 million order from Bio-Manguinhos for the purchase…
University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continue
On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…
GM and Ventec Life Systems announced joint cross-sector ventilator production program
On Mar. 20, 2020, GM and Ventec Life Systems announced they were collaborating to enable Ventec to increase…
Adaptive Biotechnologies and Microsoft expanded partnership to decode COVID-19 immune response and provide open data access
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
Todos Medical signed novel Coronavirus (COVID-19) point-of-care rapid antibody testing kit exclusive distribution agreement
On Mar. 19, 2020, Todos Medical announced it had entered into an exclusive distribution agreement for the U.S….
COVID-19 | FDA | Medicine | Therapeutics
Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
Abbott received FDA Emergency Use Authorization and launches test to detect novel Coronavirus
On Mar. 19, 2020, Abbott announced the FDA has issued Emergency Use Authorization (EUA) for the company’s molecular…
Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
On Mar. 19, 2020, Roche is working with the FDA to initiate a randomised, double-blind, placebo-controlled Phase III…
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
High-speed microscope captured fleeting brain signals
On Mar. 19, 2020, University of California, Berkeley, investigators have now built such a camera: a microscope that…
Cumberland Pharmaceuticals announced initiative to expand availability of Caldolor to treat fevers associated with Coronavirus Infections
On Apr. 1, 2020, Cumberland Pharma announced a national initiative to support hospitals and clinics that use Caldolor…
Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561K contract from the U.S. Department…
Mayo Clinic Laboratories significantly expands testing capability for the COVID-19 virus
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
LabCorp sets dedicated hours to serve the non-COVID-19 testing needs for elderly and most vulnerable people
On Mar. 19, 2020, LabCorp announced it is dedicating the first hour of service each day at its…
Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
Edmonton company Entos Pharma developing DNA vaccine against COVID-19
On Mar. 18, 2020, Entos Pharmaceuticals announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections….
Researcher proved one of Darwin’s theories of evolution 140 years after his death
On Mar. 18, 2020, Laura van Holstein and and Robert A. Foley published “Terrestrial habitats decouple the relationship…
Oxford scientists developed rapid testing technology for COVID-19
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
Abbott received FDA Emergency Use Authorization and launched test to detect novel Coronavirus
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
Leading Stanford alumni scientists and physicians launched StartX Med COVID-19 task force
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
Eli Lilly and Indiana State Department of Health partnered to accelerate COVID-19 testing using Lilly Research Laboratories
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…